280 related articles for article (PubMed ID: 21522160)
21. Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi.
Reimão JQ; Colombo FA; Pereira-Chioccola VL; Tempone AG
Exp Parasitol; 2012 Mar; 130(3):195-9. PubMed ID: 22281156
[TBL] [Abstract][Full Text] [Related]
22. In vitro antileishmanial activity and iron superoxide dismutase inhibition of arylamine Mannich base derivatives.
Martin-Montes A; Santivañez-Veliz M; Moreno-Viguri E; Martín-Escolano R; Jiménez-Montes C; Lopez-Gonzalez C; Marín C; Sanmartín C; Gutiérrez Sánchez R; Sánchez-Moreno M; Pérez-Silanes S
Parasitology; 2017 Nov; 144(13):1783-1790. PubMed ID: 28789716
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, characterization, and antileishmanial activities of gold(I) complexes involving quinoline functionalized N-heterocyclic carbenes.
Paloque L; Hemmert C; Valentin A; Gornitzka H
Eur J Med Chem; 2015 Apr; 94():22-9. PubMed ID: 25747497
[TBL] [Abstract][Full Text] [Related]
24. 2-(3-aryl-3-oxopropen-1-yl)-9-tert-butyl-paullones: a new antileishmanial chemotype.
Reichwald C; Shimony O; Dunkel U; Sacerdoti-Sierra N; Jaffe CL; Kunick C
J Med Chem; 2008 Feb; 51(3):659-65. PubMed ID: 18186603
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antileishmanial activity of C7- and C12-functionalized dehydroabietylamine derivatives.
Dea-Ayuela MA; Bilbao-Ramos P; Bolás-Fernández F; González-Cardenete MA
Eur J Med Chem; 2016 Oct; 121():445-450. PubMed ID: 27318121
[TBL] [Abstract][Full Text] [Related]
26. In vitro effects of purine and pyrimidine analogues on Leishmania donovani and Leishmania infantum promastigotes and intracellular amastigotes.
Azzouz S; Lawton P
Acta Parasitol; 2017 Sep; 62(3):582-588. PubMed ID: 28682767
[TBL] [Abstract][Full Text] [Related]
27. In vitro synergistic effect of amphotericin B and allicin on Leishmania donovani and L. infantum.
Corral MJ; González-Sánchez E; Cuquerella M; Alunda JM
Antimicrob Agents Chemother; 2014; 58(3):1596-602. PubMed ID: 24366748
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of C20-diterpenoid alkaloid derivatives in promastigotes and intracellular amastigotes of Leishmania infantum.
González P; Marín C; Rodríguez-González I; Hitos AB; Rosales MJ; Reina M; Díaz JG; González-Coloma A; Sánchez-Moreno M
Int J Antimicrob Agents; 2005 Feb; 25(2):136-41. PubMed ID: 15664483
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antitubulin activity of N1- and N4-substituted 3,5-dinitro sulfanilamides against African trypanosomes and Leishmania.
Bhattacharya G; Herman J; Delfín D; Salem MM; Barszcz T; Mollet M; Riccio G; Brun R; Werbovetz KA
J Med Chem; 2004 Mar; 47(7):1823-32. PubMed ID: 15027874
[TBL] [Abstract][Full Text] [Related]
30. Antileishmanial activity screening of 5-nitro-2-heterocyclic benzylidene hydrazides.
Rando DG; Avery MA; Tekwani BL; Khan SI; Ferreira EI
Bioorg Med Chem; 2008 Jul; 16(14):6724-31. PubMed ID: 18571927
[TBL] [Abstract][Full Text] [Related]
31. Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series.
Kieffer C; Cohen A; Verhaeghe P; Paloque L; Hutter S; Castera-Ducros C; Laget M; Rault S; Valentin A; Rathelot P; Azas N; Vanelle P
Bioorg Med Chem; 2015 May; 23(10):2377-86. PubMed ID: 25846065
[TBL] [Abstract][Full Text] [Related]
32. Leishmanicidal activity of stearylamine-bearing liposomes in vitro.
Afrin F; Dey T; Anam K; Ali N
J Parasitol; 2001 Feb; 87(1):188-93. PubMed ID: 11227889
[TBL] [Abstract][Full Text] [Related]
33. Discovery of a new antileishmanial hit in 8-nitroquinoline series.
Paloque L; Verhaeghe P; Casanova M; Castera-Ducros C; Dumètre A; Mbatchi L; Hutter S; Kraiem-M'rabet M; Laget M; Remusat V; Rault S; Rathelot P; Azas N; Vanelle P
Eur J Med Chem; 2012 Aug; 54():75-86. PubMed ID: 22608675
[TBL] [Abstract][Full Text] [Related]
34. Uptake into leishmania donovani promastigotes and antileishmanial action of an organometallic complex derived from pentamidine.
Mbongo N; Loiseau PM; Lawrence F; Craciunescu DG; Robert-Gero M
Arzneimittelforschung; 1998 Aug; 48(8):850-5. PubMed ID: 9748715
[TBL] [Abstract][Full Text] [Related]
35. Effective anti-leishmanial activity of minimalist squaramide-based compounds.
Marín C; Ximenis M; Ramirez-Macías I; Rotger C; Urbanova K; Olmo F; Martín-Escolano R; Rosales MJ; Cañas R; Gutierrez-Sánchez R; Costa A; Sánchez-Moreno M
Exp Parasitol; 2016 Nov; 170():36-49. PubMed ID: 27480054
[TBL] [Abstract][Full Text] [Related]
36. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a diospyrin derivative as antileishmanial agent and potential modulator of ornithine decarboxylase of Leishmania donovani.
Hazra S; Ghosh S; Das Sarma M; Sharma S; Das M; Saudagar P; Prajapati VK; Dubey VK; Sundar S; Hazra B
Exp Parasitol; 2013 Oct; 135(2):407-13. PubMed ID: 23973194
[TBL] [Abstract][Full Text] [Related]
38. In silico and in vitro comparative activity of novel experimental derivatives against Leishmania major and Leishmania infantum promastigotes.
Khademvatan S; Adibpour N; Eskandari A; Rezaee S; Hashemitabar M; Rahim F
Exp Parasitol; 2013 Oct; 135(2):208-16. PubMed ID: 23872452
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, structural elucidation and in vitro antiparasitic activity against Trypanosoma cruzi and Leishmania chagasi parasites of novel tetrahydro-1-benzazepine derivatives.
Gómez-Ayala S; Castrillón JA; Palma A; Leal SM; Escobar P; Bahsas A
Bioorg Med Chem; 2010 Jul; 18(13):4721-39. PubMed ID: 20627590
[TBL] [Abstract][Full Text] [Related]
40. Changes in the proteome and infectivity of Leishmania infantum induced by in vitro exposure to a nitric oxide donor.
Dea-Ayuela MA; Ordoñez-Gutierrez L; Bolás-Fernández F
Int J Med Microbiol; 2009 Mar; 299(3):221-32. PubMed ID: 18774335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
